Crescendo Care
Crescendo Care specializes in advanced precision diagnostics services, including metabolomics, proteomics, and lipidomics, supporting research and clinical needs with innovative analytical methods and tailored panels. They collaborate with medical professionals, researchers, biobanks, and companies to provide comprehensive diagnostic solutions, technological expertise, and biochemical consulting, aiming to deliver accurate, targeted, and innovative diagnostic results.
Industries
Nr. of Employees
small (1-50)
Crescendo Care
Products
Analyte catalog and downloadable panel documentation
Downloadable catalog and eBook documentation listing available analytes, targeted panels and test specifications.
Disease‑focused eBook test lists
eBook PDFs and test lists for disease areas (e.g., neurology, ALS, Parkinson's, Alzheimer's, oxidative stress, DNA damage, thiol‑metabolome) describing recommended biomarkers and panels.
Analyte catalog and downloadable panel documentation
Downloadable catalog and eBook documentation listing available analytes, targeted panels and test specifications.
Disease‑focused eBook test lists
eBook PDFs and test lists for disease areas (e.g., neurology, ALS, Parkinson's, Alzheimer's, oxidative stress, DNA damage, thiol‑metabolome) describing recommended biomarkers and panels.
Services
Quantitative targeted and untargeted analyses of metabolites, proteins and lipids across multiple biological matrices.
Execution of targeted analyte panels through UPLC‑MS/MS with instruments and workflows aligned to IVDR requirements.
Development of bioanalytical methods and prototype diagnostic and sampling kits for assay implementation and study use.
Consulting on study design, assay selection, data interpretation and development of interpretative scores.
Quantitative assays for monitoring therapeutic drugs and small molecules for research and clinical applications.
Protocols and processing workflows for a wide range of biological matrices to ensure compatibility with downstream assays.
Quantitative targeted and untargeted analyses of metabolites, proteins and lipids across multiple biological matrices.
Execution of targeted analyte panels through UPLC‑MS/MS with instruments and workflows aligned to IVDR requirements.
Development of bioanalytical methods and prototype diagnostic and sampling kits for assay implementation and study use.
Consulting on study design, assay selection, data interpretation and development of interpretative scores.
Quantitative assays for monitoring therapeutic drugs and small molecules for research and clinical applications.
Protocols and processing workflows for a wide range of biological matrices to ensure compatibility with downstream assays.
Expertise Areas
- Metabolomics
- Proteomics
- Lipidomics
- Biomarker panel design and validation
Key Technologies
- UPLC‑MS/MS
- Targeted LC‑MS/MS assays
- Untargeted metabolomics workflows
- Quantitative proteomics workflows
News & Updates
Crescendo Care offers a comprehensive quantification of biomarkers relevant to ALS, including Neurofilament heavy chain (NfH), Neurofilament light chain (NfL), SOD1, and TDP-43.
Analysis of biomarkers related to oxidative stress and redox balance, crucial for understanding disease mechanisms and therapeutic strategies.
Targeted quantification of biomarkers associated with neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s.
Crescendo Care offers a comprehensive quantification of biomarkers relevant to ALS, including Neurofilament heavy chain (NfH), Neurofilament light chain (NfL), SOD1, and TDP-43.
Analysis of biomarkers related to oxidative stress and redox balance, crucial for understanding disease mechanisms and therapeutic strategies.
Targeted quantification of biomarkers associated with neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s.